Select for export Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-024-02575-9 PubMed 38678087 Copy citation Copy BibTeX Molecular Psychiatry 2024-04-26 Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Janika Ruuska, M. B. Lemus OpenAlex Published psilocybin DepressionEating DisordersPharmacology Clinical Trial More
Select for export MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.05.5.1 Copy citation Copy BibTeX Psychiatric News 2024-04-22 Terri D’Arrigo OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.04.19.590212 Copy citation Copy BibTeX bioRxiv 2024-04-21 Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E bioRxiv PREPRINT (not peer reviewed) psilocybin Receptor PharmacologyClinical TrialAnimal Study Clinical Trial More
Select for export The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-04-18 Section for Affective Disorders; Northern Stockholm Psychiatry ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1301960 PubMed 38699449 Copy citation Copy BibTeX Frontiers in Psychiatry 2024-04-17 Julia R. Wang, Samuel J. Mendez Araque, Gina Micciche, Andrew McMillan, Emily Coughlin, Rosalie Mattiola OpenAlex Published psilocybin AnxietyEnd-of-Life DistressChronic Pain Observational Study More
Select for export Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14728214.2024.2342951 PubMed 38606899 Copy citation Copy BibTeX Unknown journal 2024-04-17 Köhne S, Hillemacher T, Glahn A, Bach P. Europe PMC Published psilocybin AddictionClinical TrialReview Article Clinical Trial More
Select for export Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-024-58318-x PubMed 38632313 Copy citation Copy BibTeX Scientific Reports 2024-04-16 Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/derm.2023.0292 PubMed 38634840 Copy citation Copy BibTeX Unknown journal 2024-04-16 Rahman SM, Salem Y, Hussain A. Europe PMC Published psilocybin Review Article Review Article More
Select for export A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00048674241240597 PubMed 38628079 Copy citation Copy BibTeX Unknown journal 2024-04-15 Hatfield SP, Thornton NL, Greenstien K, Glozier N. Europe PMC Published psilocybin Review Article Review Article More
Select for export A dual-receptor model of serotonergic psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.04.12.589282 Copy citation Copy BibTeX bioRxiv 2024-04-14 Juliani A, Chelu V, Graesser L, Safron A. bioRxiv PREPRINT (not peer reviewed) psilocybin AnxietyMechanism of ActionReceptor Pharmacology Other More
Select for export Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamapsychiatry.2024.0420 PubMed 38598200 Copy citation Copy BibTeX JAMA Psychiatry 2024-04-09 Eiko I. Fried, Ioana A. Cristea, Florian Naudet OpenAlex Published psilocybin DepressionSafety Other More
Select for export Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.isci.2024.109686 PubMed 38660396 Copy citation Copy BibTeX iScience 2024-04-08 Ram Harari, Ipsita Chatterjee, Dmitriy Getselter, Evan Elliott OpenAlex Published psilocybinpsilocin DepressionAnxietyNeuroplasticity Animal Study More
Select for export Mechanisms of therapeutic change after psychedelic treatment in OCD No abstract availability was recorded for this entry. Details DOI 10.1016/j.psychres.2024.115907 PubMed 38615521 Copy citation Copy BibTeX Psychiatry Research 2024-04-06 Gayle Maloney, Terence H. W. Ching, Stephen A. Kichuk, Christopher Pittenger, Benjamin Kelmendi OpenAlex Published psilocybin OCDMechanism of ActionReceptor Pharmacology Qualitative Study More
Select for export [Psychedelic psychiatry]. Abstract available at the source but not redistributed here. Read at source. Details PubMed 38572715 Copy citation Copy BibTeX Unknown journal 2024-04-03 López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export A double-edged sword: Insights from practitioners on the short and long-term negative effects of psilocybin-assisted psychological interventions Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2024.00337 Copy citation Copy BibTeX Journal of Psychedelic Studies 2024-04-01 M. Nordin, Jón Ingi Hlynsson, Jakob Håkansson Eklund, Per Carlbring OpenAlex Published psilocybin Safety Other More
Select for export Current situation regarding psychedelics and magic mushroom in Korea Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/j.eurpsy.2024.1695 Copy citation Copy BibTeX European Psychiatry 2024-03-31 J. S. Seo OpenAlex Published psilocybinpsilocin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Depressionen: Remission durch Psilocybin bei laufender SSRI-Therapie Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-2254-0360 Copy citation Copy BibTeX Fortschritte der Neurologie · Psychiatrie 2024-03-31 Authors unavailable OpenAlex Published psilocybin DepressionTreatment-Resistant Depression Other More
Select for export Microdosing psychedelics in the treatment of ADHD and comorbid disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/j.eurpsy.2024.44 Copy citation Copy BibTeX European Psychiatry 2024-03-31 Kim P. C. Kuypers OpenAlex Published psilocybin DepressionChronic PainNeuroplasticity Clinical Trial More
Select for export Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamanetworkopen.2024.5960 PubMed 38598236 Copy citation Copy BibTeX Unknown journal 2024-03-31 Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J. Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
Select for export Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2024.03.165 PubMed 38570038 Copy citation Copy BibTeX Unknown journal 2024-03-31 Le GH, Wong S, Badulescu S, Au H, Di Vincenzo JD, Gill H Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Systematic Review More
